173 related articles for article (PubMed ID: 35147073)
1. Menopausal hormone therapy: why we should no longer be afraid of the breast cancer risk.
Tan DA; Dayu ARB
Climacteric; 2022 Aug; 25(4):362-368. PubMed ID: 35147073
[TBL] [Abstract][Full Text] [Related]
2. Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer?
Ursin G; Tseng CC; Paganini-Hill A; Enger S; Wan PC; Formenti S; Pike MC; Ross RK
J Clin Oncol; 2002 Feb; 20(3):699-706. PubMed ID: 11821451
[TBL] [Abstract][Full Text] [Related]
3. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.
Pike MC; Ross RK
Steroids; 2000; 65(10-11):659-64. PubMed ID: 11108873
[TBL] [Abstract][Full Text] [Related]
4. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
[TBL] [Abstract][Full Text] [Related]
5. Menopausal hormone therapy and breast cancer.
Santen RJ
J Steroid Biochem Mol Biol; 2014 Jul; 142():52-61. PubMed ID: 23871991
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk association with postmenopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
Yuk JS; Kim T; Cho H; Gwak G
Eur J Endocrinol; 2024 Jan; 190(1):1-11. PubMed ID: 38128117
[TBL] [Abstract][Full Text] [Related]
7. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
Davey DA
Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and breast cancer incidence in Korean women.
Choi E; Lee JK; Baek JK; Chung Y; Kim H; Yun BH; Seo SK
Maturitas; 2024 May; 183():107946. PubMed ID: 38412593
[TBL] [Abstract][Full Text] [Related]
9. Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?
Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
J Clin Oncol; 2009 Nov; 27(31):5138-43. PubMed ID: 19752341
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
11. [Menopausal hormonal therapy and breast cancer.].
Bakhidze EV; Belyaeva AV; Berlev IV; Anisimov VN; Belyaev AM
Adv Gerontol; 2021; 34(2):277-286. PubMed ID: 34245512
[TBL] [Abstract][Full Text] [Related]
12. Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study.
Cold S; Cold F; Jensen MB; Cronin-Fenton D; Christiansen P; Ejlertsen B
J Natl Cancer Inst; 2022 Oct; 114(10):1347-1354. PubMed ID: 35854422
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women.
Wang X; Kapoor PM; Auer PL; Dennis J; Dunning AM; Wang Q; Lush M; Michailidou K; Bolla MK; Aronson KJ; Murphy RA; Brooks-Wilson A; Lee DG; Cordina-Duverger E; Guénel P; Truong T; Mulot C; Teras LR; Patel AV; Dossus L; Kaaks R; Hoppe R; Lo WY; Brüning T; Hamann U; Czene K; Gabrielson M; Hall P; Eriksson M; Jung A; Becher H; Couch FJ; Larson NL; Olson JE; Ruddy KJ; Giles GG; MacInnis RJ; Southey MC; Le Marchand L; Wilkens LR; Haiman CA; Olsson H; Augustinsson A; Krüger U; Wagner P; Scott C; Winham SJ; Vachon CM; Perou CM; Olshan AF; Troester MA; Hunter DJ; Eliassen HA; Tamimi RM; Brantley K; Andrulis IL; Figueroa J; Chanock SJ; Ahearn TU; García-Closas M; Evans GD; Newman WG; van Veen EM; Howell A; Wolk A; Håkansson N; Anton-Culver H; Ziogas A; Jones ME; Orr N; Schoemaker MJ; Swerdlow AJ; Kitahara CM; Linet M; Prentice RL; Easton DF; Milne RL; Kraft P; Chang-Claude J; Lindström S
Sci Rep; 2022 Apr; 12(1):6199. PubMed ID: 35418701
[TBL] [Abstract][Full Text] [Related]
14. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
Rossouw JE; Manson JE; Kaunitz AM; Anderson GL
Obstet Gynecol; 2013 Jan; 121(1):172-6. PubMed ID: 23262943
[TBL] [Abstract][Full Text] [Related]
15. Menopausal hormone therapy and cancer risk: An overestimated risk?
Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
[TBL] [Abstract][Full Text] [Related]
16. Menopausal hormone therapy and breast cancer risk.
Rozenberg S; Di Pietrantonio V; Vandromme J; Gilles C
Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101577. PubMed ID: 34535397
[TBL] [Abstract][Full Text] [Related]
17. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
18. Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study.
Salagame U; Banks E; O'Connell DL; Egger S; Canfell K
PLoS One; 2018; 13(11):e0205034. PubMed ID: 30403669
[TBL] [Abstract][Full Text] [Related]
19. Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study.
Rosenberg LU; Granath F; Dickman PW; Einarsdóttir K; Wedrén S; Persson I; Hall P
Breast Cancer Res; 2008; 10(5):R78. PubMed ID: 18803850
[TBL] [Abstract][Full Text] [Related]
20. Cancers in Australia in 2010 attributable to and prevented by the use of menopausal hormone therapy.
Jordan SJ; Wilson LF; Nagle CM; Green AC; Olsen CM; Bain CJ; Pandeya N; Whiteman DC; Webb PM
Aust N Z J Public Health; 2015 Oct; 39(5):434-40. PubMed ID: 26437728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
